Aptose Biosciences (APS) Stock Chart & Stock Price History → The biggest energy story ever? (From Porter & Company) (Ad) Free APS Stock Alerts C$1.66 -0.03 (-1.78%) (As of 05/1/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades Aptose Biosciences Stock Price Performance5 Day Performance-2.94%1 Month Performance-21.80%3 Month Performance-37.50%6 Month Performance-56.58%Year-To-Date Performance-50.75%1 Year Performance+126.03% Receive APS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceHave You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... APS Stock Chart for Wednesday, May, 1, 2024 APS Chart by TradingView Aptose Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/30/2024C$1.65C$1.69+2.42%C$1.70C$1.674,218 shsC$26.55 million04/29/2024C$1.70C$1.65-2.94%C$1.71C$1.6313,125 shsC$25.92 million04/26/2024C$1.62C$1.70+4.94%C$1.77C$1.6034,400 shsC$26.71 million04/25/2024C$1.66C$1.62-2.41%C$1.66C$1.5913,330 shsC$25.45 million04/24/2024C$1.65C$1.66+0.61%C$1.70C$1.6610,087 shsC$26.08 million04/23/2024C$1.70C$1.65-2.94%C$1.70C$1.658,444 shsC$25.92 million Get the Latest News and Ratings for APS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter. 04/22/2024C$1.69C$1.70+0.59%C$1.70C$1.69601 shsC$26.71 million04/19/2024C$1.75C$1.69-3.43%C$1.73C$1.6920,800 shsC$26.55 million04/18/2024C$1.75C$1.75C$1.85C$1.7410,978 shsC$27.49 million04/17/2024C$1.75C$1.75C$1.88C$1.747,550 shsC$27.49 million04/16/2024C$1.80C$1.75-2.78%C$1.82C$1.716,462 shsC$27.49 million04/15/2024C$1.90C$1.80-5.26%C$2.03C$1.8017,996 shsC$28.28 million04/12/2024C$1.90C$1.90C$1.93C$1.8613,609 shsC$29.85 million04/11/2024C$1.90C$1.90C$1.94C$1.897,990 shsC$29.85 million04/10/2024C$1.95C$1.90-2.56%C$2.04C$1.9017,409 shsC$29.85 million04/09/2024C$2.01C$1.95-2.99%C$2.01C$1.94103,934 shsC$30.63 million04/08/2024C$1.91C$2.01+5.24%C$2.04C$1.9020,352 shsC$31.58 million04/05/2024C$1.89C$1.91+1.06%C$2.07C$1.907,200 shsC$30.01 million04/04/2024C$1.99C$1.89-5.03%C$2.08C$1.8923,005 shsC$29.69 million04/03/2024C$2.08C$1.99-4.33%C$2.26C$1.9938,254 shsC$31.26 million04/02/2024C$2.11C$2.08-1.42%C$2.16C$2.0510,334 shsC$32.68 million04/01/2024C$2.24C$2.11-5.80%C$2.33C$2.1012,332 shsC$33.15 million03/29/2024C$2.24C$2.24C$2.27C$2.094,700 shsC$35.19 million03/28/2024C$2.05C$2.24+9.27%C$2.27C$2.094,710 shsC$35.19 million03/27/2024C$2.13C$2.05-3.76%C$2.05C$2.017,400 shsC$32.21 million03/26/2024C$2.05C$2.13+3.90%C$2.13C$2.061,501 shsC$33.46 million03/25/2024C$2.09C$2.05-1.91%C$2.11C$2.052,340 shsC$32.21 million03/22/2024C$2.11C$2.09-0.95%C$2.15C$2.039,133 shsC$32.83 million03/21/2024C$2.02C$2.11+4.46%C$2.12C$2.033,700 shsC$33.15 million03/20/2024C$2.01C$2.02+0.50%C$2.02C$2.01500 shsC$31.73 million03/19/2024C$2.00C$2.01+0.50%C$2.12C$1.951,300 shsC$31.58 million03/18/2024C$2.00C$2.00C$2.12C$2.005,869 shsC$31.42 million03/15/2024C$1.85C$2.00+8.11%C$2.00C$1.981,000 shsC$31.42 million03/14/2024C$1.94C$1.85-4.64%C$1.92C$1.851,926 shsC$29.06 million03/13/2024C$2.00C$1.94-3.00%C$2.00C$1.924,200 shsC$30.48 million03/12/2024C$2.09C$2.00-4.31%C$2.09C$2.004,165 shsC$31.42 million03/11/2024C$2.16C$2.09-3.24%C$2.27C$2.055,775 shsC$32.83 million03/08/2024C$2.23C$2.16-3.14%C$2.33C$2.138,221 shsC$33.93 million03/07/2024C$2.21C$2.23+0.90%C$2.28C$2.232,957 shsC$35.03 million03/06/2024C$2.38C$2.21-7.14%C$2.38C$2.198,463 shsC$34.72 millionTrump’s last act as President (Ad)You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here.03/05/2024C$2.46C$2.38-3.25%C$2.47C$2.385,650 shsC$37.39 million03/04/2024C$2.46C$2.46C$2.57C$2.454,450 shsC$38.65 million03/01/2024C$2.40C$2.46+2.50%C$2.46C$2.45300 shsC$38.65 million02/29/2024C$2.48C$2.40-3.23%C$2.46C$2.407,503 shsC$37.70 million02/28/2024C$2.57C$2.48-3.50%C$2.55C$2.481,902 shsC$38.96 million02/27/2024C$2.53C$2.57+1.58%C$2.57C$2.53248 shsC$40.38 million02/26/2024C$2.44C$2.53+3.69%C$2.60C$2.4113,150 shsC$39.75 million02/23/2024C$2.43C$2.44+0.41%C$2.51C$2.411,375 shsC$38.33 million02/22/2024C$2.51C$2.43-3.19%C$2.50C$2.432,318 shsC$38.18 million02/21/2024C$2.61C$2.51-3.83%C$2.65C$2.503,581 shsC$39.43 million02/20/2024C$2.62C$2.61-0.38%C$2.63C$2.5814,700 shsC$41.00 million02/19/2024C$2.62C$2.62C$2.77C$2.60877 shsC$41.16 million02/16/2024C$2.74C$2.62-4.38%C$2.77C$2.60877 shsC$41.16 million02/15/2024C$2.61C$2.74+4.98%C$2.74C$2.62633 shsC$43.05 million02/14/2024C$2.71C$2.61-3.69%C$2.67C$2.503,592 shsC$41.00 million02/13/2024C$2.78C$2.71-2.52%C$2.71C$2.652,195 shsC$42.57 million02/12/2024C$2.70C$2.78+2.96%C$2.82C$2.771,420 shsC$43.67 million02/09/2024C$2.75C$2.70-1.82%C$2.78C$2.691,794 shsC$42.42 million02/08/2024C$2.77C$2.75-0.72%C$2.78C$2.75300 shsC$43.20 million02/07/2024C$2.87C$2.77-3.48%C$2.94C$2.765,500 shsC$43.52 million02/06/2024C$2.72C$2.87+5.51%C$2.92C$2.7515,492 shsC$45.09 million02/05/2024C$2.67C$2.72+1.87%C$2.75C$2.659,766 shsC$21.60 million02/02/2024C$2.64C$2.67+1.14%C$2.69C$2.65800 shsC$21.20 million02/01/2024C$2.70C$2.64-2.22%C$2.69C$2.641,301 shsC$20.96 million01/31/2024C$2.63C$2.70+2.66%C$2.70C$2.562,200 shsC$21.44 million01/30/2024C$2.60C$2.63+1.15%C$2.65C$2.521,110 shsC$20.88 million Related Companies: COV Stock Chart GSD Stock Chart CZO Stock Chart KNE Stock Chart IBT Stock Chart SBM Stock Chart RVX Stock Chart ATE Stock Chart AEZS Stock Chart HBP Stock Chart Receive APS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:APS) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlace😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersForget Nvidia. This is the future of AIPorter & CompanyBiden out June 13; Kamala won’t replace him?Paradigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptose Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.